RBC Bioscience (ROCO:6848) COGS-to-Revenue : 0.56 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience COGS-to-Revenue?

RBC Bioscience's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$46.8 Mil. Its Revenue for the six months ended in Dec. 2023 was NT$83.5 Mil.

RBC Bioscience's COGS to Revenue for the six months ended in Dec. 2023 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. RBC Bioscience's Gross Margin % for the six months ended in Dec. 2023 was 43.95%.

RBC Bioscience COGS-to-Revenue Historical Data

The historical data trend for RBC Bioscience's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience COGS-to-Revenue Chart

RBC Bioscience Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.48

0.53

0.58

RBC Bioscience Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial					0.59	0.55	0.62	0.59	0.56

RBC Bioscience COGS-to-Revenue Calculation

RBC Bioscience's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	99.572	/	172.467
	=	0.58

RBC Bioscience's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	46.818	/	83.527
	=	0.56

RBC Bioscience (ROCO:6848) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

RBC Bioscience's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	46.818 / 83.527
	=	43.95 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

RBC Bioscience COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145

Website

https://www.rbcbioscience.com

RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines